| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.0019 | 1 |